Skip to main content
. Author manuscript; available in PMC: 2023 Feb 18.
Published in final edited form as: Circ Res. 2022 Feb 17;130(4):652–672. doi: 10.1161/CIRCRESAHA.121.319895

Figure 5. Contemporary approach to prescribing hormone therapy and hormone therapy risk assessment.

Figure 5.

Hormone therapy is appropriate for treatment of vasomotor symptoms in women who are otherwise healthy at the time of menopause, within 10 years of menopause, and under age 60 years. However, the decision to prescribe hormone therapy should still consider a woman’s individual cardiovascular disease risk factors and employ a shared decision-making approach.